Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in TRAW — Traws Pharma, Inc.

CIK 1214717 BOSTON, MA
Back to TRAW Full portfolio

Position in TRAW

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$93,546
-$47,551 QoQ
Shares Held
111,365
+44.4% QoQ
Ownership
0.725%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 34 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRAW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. TRAW ranks #448 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in TRAW

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,546 111,365
2026-03-31 $141,097 77,103
2025-12-31 $69,667 61,653
2025-09-30 $80,363 43,440
2025-06-30 $52,872 35,725
2025-03-31 $76,771 33,379
2024-12-31 $184,712 20,801
2024-06-30 $100,838 224,086
2024-03-31 $194,786 192,858
2023-12-31 $144,643 192,858
2023-09-30 $136,929 192,858
2023-06-30 $200,011 169,501
2023-03-31 $123,735 169,501
2022-12-31 $110,175 169,501
2022-09-30 $149,465 169,847
2022-06-30 $224,198 169,847
2022-03-31 $299,862 162,969
2021-12-31 $415,570 162,969
2021-09-30 $679,556 177,430
2021-06-30 $990,851 142,980